Amneal Pharmaceuticals (AMRX) Work In Process (2017 - 2020)

Amneal Pharmaceuticals' Work In Process history runs 4 years deep, the most recent figure standing at $53.1 million for Q1 2020.

• On a quarterly basis, Work In Process changed N/A year-over-year to $53.1 million in Q1 2020; TTM through Mar 2020 was $53.1 million, a N/A change from a year earlier, with the FY2019 full-year figure at $58.2 million, up 7.45% from the prior year.
• Work In Process retreated to $53.1 million in Q1 2020 per AMRX's latest filing, from $58.2 million in the prior quarter.
• Across five years, Work In Process topped out at $59.2 million in Q2 2018 and bottomed at $38.1 million in Q4 2017.
• The 4-year median for Work In Process is $52.1 million (2018), against an average of $50.4 million.
• Across the five-year window, Work In Process surged 41.96% in 2018 and plunged 35.13% in 2019, its largest moves.
• Year by year, Work In Process stood at $38.1 million in 2017, then jumped by 41.96% to $54.2 million in 2018, then increased by 7.45% to $58.2 million in 2019, then decreased by 8.79% to $53.1 million in 2020.
• Per Business Quant, the three latest AMRX Work In Process figures stand at $53.1 million (Q1 2020), $58.2 million (Q4 2019), and $50.8 million (Q3 2019).